FDA Evaluating Study That Found Increased Death Risk From Paclitaxel Arterial Devices

(January 22, 2019, 9:06 AM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Jan. 17 said it is evaluating a recent review and meta-analysis showing an increased risk of death among patients treated with...
To view the full article, register now.